TAM
FATE icon

Tyers Asset Management’s Fate Therapeutics FATE Stock Holding History

Tyers Asset Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$19K Hold
1,232
– – ﹤0.01% 955
2019
Q2 		$25K Hold
1,232
– – ﹤0.01% 952
2019
Q1 		$22K Hold
1,232
– – ﹤0.01% 952
2018
Q4 		$16K Buy
+1,232
New +$17.2K ﹤0.01% 922

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
GH
Grosvenor Holdings Chicago, Illinois $512M AUM 19.57% 1-Year Est. Return

Tyers Asset Management's FATE Position: Q3 2019 in Review

Tyers Asset Management held its Fate Therapeutics (FATE) position steady in Q3 2019 at 1,232 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #955.

Tyers Asset Management first reported a position in FATE in Q4 2018 and has held it in 4 quarters since. The position peaked at $25K in Q2 2019. 149 funds tracked by Wall St. Rank hold FATE as of Q3 2019.

  • Tyers Asset Management held 1,232 shares of Fate Therapeutics worth $19K as of Q3 2019.
  • Tyers Asset Management left its Fate Therapeutics share count unchanged in Q3 2019.
  • Fate Therapeutics made up ﹤0.01% of Tyers Asset Management's portfolio in Q3 2019, its #955 holding.
  • Tyers Asset Management first reported a position in Fate Therapeutics in Q4 2018 and has held it in 4 quarters since.
  • Tyers Asset Management's Fate Therapeutics position peaked at $25K in Q2 2019.
  • 149 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.